journal article·2011-08Open access

Hematopoietic Derived Cell Infiltration of the Intestinal Tumor Microenvironment inApcMin/+Mice

Celestia Davis, Robert Price, Grishma Acharya, Troy Baudino, Thomas Borg, Franklin G. Berger, Maria Marjorette O. Peña

Microscopy and Microanalysis· Volume 17· Issue 4

Abstract

Abstract Tumors consist of a heterogeneous population of neoplastic cells infiltrated by an equally heterogeneous collection of nonneoplastic cells that comprise the tumor microenvironment. Tumor growth, invasion, and metastasis depend on multiple interactions between these cells. To assess their potential as therapeutic targets or vehicles for tumor specific delivery of therapeutic agents, we examined the contribution of bone marrow derived cells (BMDCs) to the intestinal tumor microenvironment. Hematopoietic stem cells expressing the enhanced green fluorescent protein (eGFP) were transplanted into lethally irradiatedApcMin/+mice, and their engraftment was analyzed by confocal microscopy. The results showed abundant infiltration of eGFP cells into the small intestine, colon, and spleen compared to heart, muscle, liver, lung, and kidney. Within the intestine, there was a pronounced gradient of engraftment along the anterior to posterior axis, with enhanced infiltration into adenomas. Immunofluorescence analysis showed that osteopontin was expressed in tumor stromal cells but not in nontumor stromal populations, suggesting that gene expression in these cells is distinct. Tumor vasculature inApcMin/+mice was chaotic compared to normal intestinal regions. Our data suggest that BMDCs can be harnessed for tumor-targeted therapies to enhance antitumor efficacy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Cancer Cells and Metastasis · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. 10.1093/annonc/mdl02910.1093/annonc/mdl029 ↗
2. 10.1016/j.ccr.2007.12.00410.1016/j.ccr.2007.12.004 ↗
3. 10.1016/j.leukres.2003.10.03310.1016/j.leukres.2003.10.033 ↗
4. 10.1038/3506501610.1038/35065016 ↗
5. 10.1053/j.gastro.2004.11.01010.1053/j.gastro.2004.11.010 ↗
6. 10.1189/jlb.120360910.1189/jlb.1203609 ↗
7. 10.1158/0008-5472.CAN-04-310410.1158/0008-5472.CAN-04-3104 ↗
8. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy
9. 10.1083/jcb.116.6.151710.1083/jcb.116.6.1517 ↗
10. 10.1038/nm140010.1038/nm1400 ↗
11. 10.1007/s00262-007-0365-510.1007/s00262-007-0365-5 ↗
12. 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A ↗
13. 10.1016/j.ccr.2005.05.01910.1016/j.ccr.2005.05.019 ↗
14. 10.1038/nrc280410.1038/nrc2804 ↗
15. 10.1038/3507012910.1038/35070129 ↗
16. 10.1038/nrc107410.1038/nrc1074 ↗
17. 10.1016/S0092-8674(00)81333-110.1016/S0092-8674(00)81333-1 ↗
18. 10.1126/science.112913910.1126/science.1129139 ↗
19. 10.1007/978-1-4684-5607-3_610.1007/978-1-4684-5607-3_6 ↗
20. 10.1016/j.critrevonc.2008.06.00410.1016/j.critrevonc.2008.06.004 ↗
21. 2009
22. 10.1073/pnas.070462010410.1073/pnas.0704620104 ↗
23. 10.1158/0008-5472.CAN-09-030410.1158/0008-5472.CAN-09-0304 ↗
24. 10.1084/jem.193.6.F2310.1084/jem.193.6.F23 ↗
25. 10.1038/sj.leu.240364310.1038/sj.leu.2403643 ↗
26. 10.1016/S0076-6879(08)02811-510.1016/S0076-6879(08)02811-5 ↗
27. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents10.4049/jimmunol.163.12.6442 ↗
28. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer
29. 10.1111/j.1601-0825.2008.01471.x10.1111/j.1601-0825.2008.01471.x ↗
30. 10.1158/0008-5472.CAN-03-326410.1158/0008-5472.CAN-03-3264 ↗
31. 10.1016/j.canlet.2003.10.03310.1016/j.canlet.2003.10.033 ↗
32. 10.1038/nrc92510.1038/nrc925 ↗
33. 10.1073/pnas.071051610510.1073/pnas.0710516105 ↗
34. 10.1038/ni115810.1038/ni1158 ↗
35. 10.1017/S143192760999119X10.1017/S143192760999119X ↗
36. Studies of neoplasia in the Min mouse
37. 10.1007/s12307-008-0010-710.1007/s12307-008-0010-7 ↗
38. 10.1038/nature0132210.1038/nature01322 ↗
39. 10.1172/JCI1298010.1172/JCI12980 ↗
40. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice
41. 10.1038/sj.gt.330188310.1038/sj.gt.3301883 ↗
42. 10.1182/blood-2002-04-107610.1182/blood-2002-04-1076 ↗
43. 10.1158/0008-5472.CAN-03-330110.1158/0008-5472.CAN-03-3301 ↗
44. 10.1158/0008-5472.CAN-04-041510.1158/0008-5472.CAN-04-0415 ↗
45. 10.1084/jem.193.6.72710.1084/jem.193.6.727 ↗
46. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia
47. 10.1158/0008-5472.CAN-09-369010.1158/0008-5472.CAN-09-3690 ↗
48. 10.1006/geno.1993.125110.1006/geno.1993.1251 ↗
49. 10.1126/science.229672210.1126/science.2296722 ↗
50. 10.1073/pnas.050859310310.1073/pnas.0508593103 ↗
51. 10.1016/S1040-8428(03)00057-X10.1016/S1040-8428(03)00057-X ↗
52. Thymidylate synthetase—A target enzyme in cancer chemotherapy
53. 10.1016/S1535-6108(02)00125-310.1016/S1535-6108(02)00125-3 ↗
54. 10.4161/cc.5.15.311210.4161/cc.5.15.3112 ↗